Pfizer to sell about $3.25 billion stake in Sensodyne-maker Haleon, bookrunner says

Pfizer's stake sale in British consumer healthcare company Haleon has been upsized by 100 million shares to 640 million shares worth about $3.25 billion with strong demand from investors, a bookrunner familiar with the offering said on Monday.